Biofrontera Inc. — Director's Dealing 2026

Mar 7, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2026-03-04

Reporting Person: Jones George Patrick (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-03-04	Restricted Stock Units	$	A	50000	Acquired		Common Stock (50000)	Direct
2026-03-04	Employee stock option (right to buy)	$0.90	A	50000	Acquired	2036-03-04	Common Stock (50000)	Direct

Footnotes

F1: The option vests in two equal installments, the first of which will take place on September 4, 2026 and the second of which will take place on March 4, 2027.

F2: Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 3. The reporting person received the restricted stock units as an award for no consideration.

F3: The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on March 4, 2027. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

F4: Options with different terms are not included